Search

Author/Creator Aharon, Anat

1. BNT162b2 mRNA COVID‐19 vaccine booster induces seroconversion in patients with B‐cell non‐Hodgkin lymphoma who failed to respond to two prior vaccine doses. (25th January 2022)

Authors:
Avivi, Irit; Luttwak, Efrat; Saiag, Esther; Halperin, Tami; Haberman, Shira; Sarig, Ariel; Levi, Sivan; Aharon, Anat; Herishanu, Yair; Perry, Chava
Journal:
British journal of haematology
Issue:
Volume 196:Number 6(2022)
Page Start:
1329
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Humoral response rate and predictors of response to BNT162b2 mRNA COVID19 vaccine in patients with multiple myeloma. (1st July 2021)

Authors:
Avivi, Irit; Balaban, Roi; Shragai, Tamir; Sheffer, Gabi; Morales, Miguel; Aharon, Anat; Lowenton‐Spier, Noa; Trestman, Svetlana; Perry, Chava; Benyamini, Noam; Mittelman, Moshe; Tabib, Yaara; Bar Lev, Tali; Zavaro, Mor; Herishanu, Yair; Luttwak, Efrat; Cohen, Yael C.
Journal:
British journal of haematology
Issue:
Volume 195:Number 2(2021)
Page Start:
186
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Tumor‐derived microparticles induce bone marrow‐derived cell mobilization and tumor homing: A process regulated by osteopontin. Issue 2 (13th January 2014)

Authors:
Fremder, Ella; Munster, Michal; Aharon, Anat; Miller, Valeria; Gingis‐Velitski, Svetlana; Voloshin, Tali; Alishekevitz, Dror; Bril, Rotem; Scherer, Stefan J.; Loven, David; Brenner, Benjamin; Shaked, Yuval
Journal:
International journal of cancer
Issue:
Volume 135:Issue 2(2014:Jul. 15)
Page Start:
270
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗